Tryptamine Induces Axonopathy and Mitochondriopathy Mimicking Neurodegenerative Diseases via Tryptophanyl-tRNA Deficiency

Publisher： Bentham Science Publishers

E-ISSN： 1875-5828|10|9|987-1004

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.10, Iss.9, 2013-10, pp. : 987-1004

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tryptamine Induces Tryptophanyl-tRNA Synthetase-Mediated Neurodegeneration With Neurofibrillary Tangles in Human Cell and Mouse Models

By  

NeuroMolecular Medicine, Vol. 9, Iss. 1, 2007-02 ,pp. : 55-82

Humana Press, Inc

Access to resources Recommend Favorite

Tau and Axonopathy in Neurodegenerative Disorders

By Higuchi M.     Trojanowski J.Q.  

NeuroMolecular Medicine, Vol. 2, Iss. 2, 2002-06 ,pp. : 131-150

Humana Press, Inc

Access to resources Recommend Favorite

RNA Interference Technologies for Understanding and Treating Neurodegenerative Diseases

By Lu Bingwei  

NeuroMolecular Medicine, Vol. 6, Iss. 1, 2004-08 ,pp. : 1-12

Humana Press, Inc

Access to resources Recommend Favorite

Transglutaminase activation in neurodegenerative diseases

By Jeitner Thomas M   Muma Nancy A   Battaile Kevin P   Cooper Arthur JL  

Future Neurology, Vol. 4, Iss. 4, 2009-07 ,pp. : 449-467

Future Medicine

Access to resources Recommend Favorite

Polyphenols and neurodegenerative diseases

By Barreto George E.   Guedes Rubem C. A.  

Nutritional Neuroscience, Vol. 15, Iss. 3, 2012-05 ,pp. : 92-93

Maney Publishing

Access to resources Recommend Favorite